Time in the therapeutic range during warfarin therapy in Japanese patients with non-valvular atrial fibrillation. - A multicenter study of its status and infuential factors-.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Circulation Journal

• Publication date

  2011-08-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1253/CIRCJ.CJ-11-0350PMID 21737950
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

  2011cited by this paper
• Investigation of optimal anticoagulation strategy for stroke prevention in Japanese patients with atrial fibrillation--the J-RHYTHM Registry study design.

  2011cited by this paper
• Efficacy and safety of dabigatran vs. warfarin in patients with atrial fibrillation--sub-analysis in Japanese population in RE-LY trial.

  2011cited by this paper
• 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2011cited by this paper
• Quality of Wafarin Control Affects the Incidence of Stroke in Elderly Patients with Atrial Fibrillation

  2010cited by this paper
• Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial.

  2010cited by this paper
• Guidelines for pharmacotherapy of atrial fibrillation (JCS 2008): digest version.

  2010cited by this paper
• Quality of warfarin control affects the incidence of stroke in elderly patients with atrial fibrillation.

  2010cited by this paper
• Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2008) : Digest Version

  2010cited by this paper
• Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

  2010cited by this paper
• Antithrombotic therapy. ESC guidelines vs JCS guidelines.

  2010cited by this paper
• Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

  2010cited by this paper
• Dabigatran versus warfarin in patients with atrial fibrillation.

  2009cited by this paper
• Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range

  2008cited by this paper
• Dual Antithrombotic Therapy Increases Severe Bleeding Events in Patients With Stroke and Cardiovascular Disease: A Prospective, Multicenter, Observational Study

  2008cited by this paper
• Barriers to the Use of Anticoagulation for Nonvalvular Atrial Fibrillation: A Representative Survey of Australian Family Physicians

  2008cited by this paper
• Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V.

  2007cited by this paper
• Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study).

  2006cited by this paper
• Effect of study setting on anticoagulation control: a systematic review and metaregression.

  2006cited by this paper
• Effective anticoagulation therapy: defining the gap between clinical studies and clinical practice.

  2004cited by this paper
• Oral anticoagulants in the elderly

  2003cited by this paper
• Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.

  2003cited by this paper
• Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation

  2001cited by this paper
• Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.

  2001cited by this paper
• Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation

  1999cited by this paper
• Interactions of Warfarin with Drugs and Food

  1994cited by this paper
• A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy

  1993cited by this paper

• Fixed dose versus 3-day loading dose warfarin initiation in atrial fibrillation: effects on INR stabilization and time in the therapeutic range.

  2026cites this paper
• Anticoagulation control of warfarin in anticoagulation medication therapy adherence clinics

  2025cites this paper
• AI‐assisted warfarin dose optimisation with CURATE.AI for clinical impact: Retrospective data analysis

  2025cites this paper
• JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias

  2022cites this paper
• JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias

  2022cites this paper
• Rivaroxiban versus Warfarin in management of deep venous thrombosis (DVT)

  2022cites this paper
• Time in therapeutic range values of patients using warfarin and factors that influence time in therapeutic range.

  2021cites this paper
• Low Quality of Warfarin Therapy is Associated With Female Gender but Not With Polypharmacy in Patients With Atrial Fibrillation

  2021cites this paper
• Physician–Pharmacist Collaborative Clinic Model to Improve Anticoagulation Quality in Atrial Fibrillation Patients Receiving Warfarin: An Analysis of Time in Therapeutic Range and a Nomogram Development

  2021cites this paper
• Differences in autoimmunity factors based on the activity of thromboangiitis obliterans.

  2021cites this paper
• Anticoagulation Quality of Warfarin and the Role of Physician–Pharmacist Collaborative Clinics in the Treatment of Patients Receiving Warfarin: A Retrospective, Observational, Single-Center Study

  2021influential citation
• ASSOCIATION OF INR QUALITY WITH COMPLICATIONS AMONG PATIENTS ON WARFARIN THERAPY IN HOSPITAL SULTAN ISMAIL PETRA, KELANTAN STATE

  2020cites this paper
• Warfarin control in Hong Kong clinical practice CURRENT STATUS: POSTED

  2020cites this paper
• Non-Clinical Factors Associated with International Normalized Ratio Control in Patients on Warfarin Therapy: A Review Paper

  2020influential citation
• Discrepancy Among Self-Reported Adherence, Prescription Refills, and Actual Anticoagulant Control.

  2019influential citation
• Secondary stroke prevention and guideline adherent antithrombotic treatment in patients with atrial fibrillation: Insights from the Gulf Survey of atrial fibrillation events (Gulf SAFE).

  2019cites this paper
• Personalised approaches to antithrombotic therapies : insights from linked electronic health records

  2018cites this paper
• Time in Therapeutic Range of Oral Vitamin K Antagonists in Hospitalized Elderly Patients

  2018cites this paper
• Temporal trends of time in therapeutic range and incidence of cardiovascular events in patients with non-valvular atrial fibrillation.

  2018cites this paper
• Rivaroxaban vs. warfarin on extended deep venous thromboembolism treatment: A cost analysis

  2018cites this paper
• Impact of Aspirin on Warfarin Control as Measured by Time in Therapeutic Range

  2018cites this paper
• Comparison of mid-term outcomes between patients with and without atrial fibrillation undergoing coronary stenting in the second-generation drug-eluting stent era: from the SHINANO registry

  2017cites this paper
• Real‐World Clinical Characteristics and Treatment Patterns of Individuals Aged 80 and Older with Nonvalvular Atrial Fibrillation: Results from the ReAl‐life Multicenter Survey Evaluating Stroke Study

  2017cites this paper
• A cost-utility analysis for catheter ablation of atrial fibrillation in combination with warfarin and dabigatran based on the CHADS2 score in Japan.

  2017cites this paper
• Effects of the quality of warfarin therapy on the development of ischemic and hemorrhagic events in elderly Japanese patients with nonvalvular atrial fibrillation

  2017cites this paper
• The Time in Therapeutic Range and Bleeding Complications of Warfarin in Different Geographic Regions of Turkey: A Subgroup Analysis of WARFARIN-TR Study

  2017cites this paper
• Predictors of International Normalized Ratio Variability in Patients With Atrial Fibrillation Under Warfarin Therapy.

  2017cites this paper
• Effects of Smoking on Ischemic Stroke, Intracranial Hemorrhage, and Coronary Artery Events in Japanese Patients With Non-Valvular Atrial Fibrillation.

  2017cites this paper
• Factors influencing warfarin control in Australia and Singapore.

  2017influential citation
• Persistence of Oral Anticoagulants in Japanese Patients with Atrial Fibrillation:Non-Vitamin K Antagonist Oral Anticoagulant versus Warfarin

  2016cites this paper
• Anticoagulation treatment in patients with a mechanical heart valve

  2016cites this paper
• Quality of warfarin control in atrial fibrillation patients in South East Queensland, Australia

  2016influential citation
• Clinical and economic impact of rivaroxaban on the burden of atrial fibrillation: The case study of Japan

  2016cites this paper
• Age is associated with time in therapeutic range for warfarin therapy in patients with atrial fibrillation

  2016cites this paper
• QUALITY OF ORAL ANTICOAGULATION MANAGEMENT AMONG PATIENTS ON FOLLOW UP AT KENYATTA NATIONAL HOSPITAL SALOME WANJIRU KARURI (B. PHARM) U56/75585/2014

  2016cites this paper
• Renal Function and Treatment Persistence with Non-Vitamin K Antagonist Oral Anticoagulants in Japanese Patients with Atrial Fibrillation: A Single-Center Experience

  2016cites this paper
• Oral anticoagulation in octogenarians with atrial fibrillation.

  2016cites this paper
• Anticoagulation treatment in patients with a mechanical heart valve

  2016cites this paper
• APOLLO I: Anticoagulation control in atrial fibrillation.

  2015cites this paper
• Prediction of left atrial thrombi in patients with atrial tachyarrhythmias during warfarin administration: retrospective study in Hyogo College of Medicine

  2015cites this paper
• APOLO I: controlo da hipocoagulação na fibrilhação auricular

  2015cites this paper
• The effect of VKORC1 (-1639 G>A) gene polymorphism and its related clotting factor IIa and Xa on warfarin therapy in patients with atrial fibrillation: a multi-ethnic Sarawak population study

  2015influential citation
• Long-term outcomes after St. Jude Medical mechanical valve implantation.

  2015cites this paper
• Association between smoking habits and the first-time appearance of atrial fibrillation in Japanese patients: Evidence from the Shinken Database.

  2015cites this paper
• Analysis of factors affecting time in therapeutic range control after warfarin administration.

  2015cites this paper
• Oral anticoagulation in Japanese patients with atrial fibrillation – insight to the use of non-vitamin K antagonist oral anticoagulants.

  2015cites this paper
• Efficacy and safety of non-vitamin K antagonist oral anticoagulants vs. warfarin in Japanese patients with atrial fibrillation – meta-analysis.

  2015cites this paper
• [Laboratory monitoring of the efficacy and safety of anticoagulants].

  2014cites this paper
• Introduction of point-of-care testing in Japanese outpatient clinics is associated with improvement in time in therapeutic range in anticoagulant-treated patients.

  2014cites this paper
• Inappropriate use of oral anticoagulants for patients with atrial fibrillation.

  2014cites this paper
• Measures of vitamin K antagonist control reported in atrial fibrillation and venous thromboembolism studies: a systematic review

  2014cites this paper
• Thrombin and FXa plasma concentration levels in patients with atrial fibrillation on long term warfarin therapy

  2014cites this paper
• An Explanation of Recommendation Differences: Illustrations from Recent Atrial Fibrillation Guidelines

  2014cites this paper
• Warfarin therapy still survives as an anticoagulation treatment for patients with atrial fibrillation.

  2014cites this paper
• Long-term PT-INR levels and the clinical events in the patients with non-valvular atrial fibrillation: a special reference to low-intensity warfarin therapy.

  2014cites this paper
• [Neurological common diseases in the super-elder-society. Topics: II. Stroke: 4. Latest stroke prevention in elderly patients with atrial fibrillation].

  2014cites this paper
• Effects of smoking habit on the prevalence of atrial fibrillation in Japanese patients with special reference to sex differences.

  2013cites this paper
• Bleeding events and associated factors in a cohort of adult patients taking warfarin in Sarawak, Malaysia

  2013cites this paper
• Percutaneous closure of the left atrial appendage using the Amplatzer Cardiac Plug in patients with atrial fibrillation: evaluation of safety and feasibility.

  2013cites this paper
• Does Warfarin Use Impact Hospital Length of Stay? A Retrospective Study Looking at Patients Treated for Atrial Fibrillation

  2013cites this paper
• Patient factors against stable control of warfarin therapy for Japanese non-valvular atrial fibrillation patients.

  2013cites this paper
• Relationship between CHADS2 score and efficacy of antiarrhythmic drug therapy in patients with paroxysmal atrial fibrillation.

  2013cites this paper
• Relationship Between CHADS 2 Score and Efficacy of Antiarrhythmic Drug Therapy in Patients With Paroxysmal Atrial Fibrillation

  2013cites this paper
• [How to properly use warfarin and new anticoagulants].

  2013cites this paper
• Anticoagulation control quality affects the D-dimer levels of atrial fibrillation patients.

  2012cites this paper
• Gender-specific relationship between serum uric acid level and atrial fibrillation prevalence.

  2012cites this paper
• A unique warfarin therapy in Japan.

  2011cites this paper
• A Unique Warfarin Therapy in Japan : Is It Appropriate or Eccentric?

  2011cites this paper